Our Lady's Chilrden's Hospital, Ireland Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03590171
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Our Lady's Chilrden's Hospital (Co-Sponsor Ireland)